Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 18.5B | 13.4B | 10.4B | 10.1B |
Cost of revenue | 14.3B | 9.9B | 7.4B | 7.2B |
Gross profit | 4.3B | 3.4B | 3.0B | 2.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 247.1M | 209M | 199.5M | 210.5M |
Operating income | 2.0B | 1.4B | 1.1B | 1.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 336.5M | 249.4M | 189.2M | 217.4M |
Other income expense | — | — | — | — |
Pretax income | 1.8B | 1.2B | 1.0B | 881.4M |
Tax provision | 511.2M | 347.7M | 313.9M | 264.2M |
Net income | 1.3B | 865.5M | 695.1M | 617.2M |
Basic EPS | — | 25.9 | 21.2 | 19.0 |
Diluted EPS | — | 25.9 | 21.2 | 19.0 |
Basic average shares | — | 31.6M | 31.6M | 31.6M |
Diluted average shares | — | 31.6M | 31.6M | 31.6M |
EBITDA | 2.3B | 1.6B | 1.3B | 1.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | -125.4M | -45.1M | -24.4M | -15.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |